Bifidobacterium 35624 4 mg per capsule Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 4 mg per capsule
Reference Brands: -
Category: Nutraceuticals
Bifidobacterium 35624 is a patented probiotic strain used to support digestive health. It helps maintain a healthy balance of gut bacteria, alleviating symptoms such as bloating, gas, and abdominal discomfort. The probiotic is available as oral capsules and is typically taken once daily. It is gluten-free, vegetarian, and does not require refrigeration.
Manufacture or export Bifidobacterium 35624? List it or send an offer →
Product Description:
Bifidobacterium longum subsp. infantis 35624 is a single, specific probiotic strain originally isolated from the human gut. It is one of the most studied strains for irritable bowel syndrome: controlled trials found that it reduced abdominal pain, bloating and bowel habit disturbance in some patients, although results have not been consistent across all studies. Its effects are thought to involve modulation of the gut immune response.
It is taken as one capsule daily, and benefit is usually assessed after about four weeks. It is well tolerated; mild gas or bloating can occur at first. As with any probiotic, caution is advised in severely immunocompromised patients. Results for this strain do not transfer to other Bifidobacterium strains, even closely related ones — probiotic effects are strain-specific.
Sourcing notes. Strain 35624 is proprietary. Genuine material comes only from the strain owner or its licensees, and a product cannot lawfully claim this strain unless it contains it. Buyers should ask for the licence and for genetic identification of the strain. The stated amount (about 4 mg per capsule) corresponds to around one billion live bacteria; viable count at the end of shelf life is the specification that matters.
Bifidobacterium 35624 — third party manufacturing & bulk supply
Bifidobacterium 35624 4 mg per capsule is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Bifidobacterium 35624 is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Bifidobacterium 35624 listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Bifidobacterium 35624 →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Related Products
Bacopa Monnieri
Strength:
250 mg, 300 mg, 500 mg
Form: Capsules, Tablets, Powders, Liquid extracts
Reference Brands: -
View DetailsL-Alpha-Glycerylphosphorylcholine
Strength:
300 mg, 400 mg, 600 mg
Form: Capsules, Tablets, Powders
Reference Brands: -
View DetailsUsually answered within 48 hours | GMP documents shared before you commit